Depression App Moodpath Turns One Year Old: Over 100.000 Users, more than 25.000 Electronic Referral Letters Created

MoodpathOctober 10, 2017 was the date of the World Mental Health Day. On the same day, Moodpath, the app for the early recognition of depression, has been on the market for one year. Moodpath has been downloaded by more than 100.000 users and more than 25.000 referral letters for further treatment by healthcare professionals have been created by the app. Moodpath is already the number one app for the term “depression” on the iOS App Stores in the UK, Canada, Australia, Germany, Austria, Switzerland, and the Netherlands. The user ratings are overwhelmingly positive (with an average rating of 4.7 out of 5).

The CE-certified medical app aims to improve the recognition of depression - with the help of an algorithm and the analysis of anonymous data. "To this day, 90 percent of the people affected don't get the treatment they need. According to the WHO more than 320 million people worldwide suffer from depression. And every month there are more than 30 million Google searches on this topic. There simply is no alternative to the complementary use of digital medical products like Moodpath, if we finally want to reduce the treatment gap in mental healthcare," says Felix Frauendorf, founder of Berlin-based Aurora Health, the company behind Moodpath.

The scientific validation of Moodpath is of particular importance to the founders. Three studies are currently being conducted, including one at the Free University of Berlin. Additional research projects in the United States are about to commence: "We are currently in contact with researchers and data scientists at Columbia University and Stanford. It is our goal to constantly use studies and the latest scientific findings to further develop our mobile depression screening," stresses Mark Goering, clinical psychologist and founder of Aurora Health. Moodpath will shortly expand its services to include customized daily plans. These plans are individually tailored to the needs of each user, adapt to progress made, and include psychological exercises based on cognitive behavioural therapy.

For further information, please visit:
http://www.moodpath.io

About Moodpath
Moodpath is a mobile mental health app for the detection and treatment of depression. The app includes a user-friendly screening and improvement program. Based on an algorithm the program adapts to each individual user. The app is linked to Aurora, a platform that supports mental healthcare practitioners. Moodpath connects doctors and patients with a collaborative digital infrastructure, improving efficiency, accessibility and outcome for all stakeholders in the mental healthcare system.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...